Loading…
Increased IL‐15 production of muscle cells in polymyositis and dermatomyositis
In polymyositis (PM)/dermatomyositis (DM), various cytokines, especially macrophage‐derived cytokines such as IL‐1α, IL‐1β and tumor necrosis factor (TNF)‐α, are expressed in the inflammatory foci. We previously reported that IL‐15, a novel cytokine with a biological activity similar to that of IL‐2...
Saved in:
Published in: | International immunology 2002-08, Vol.14 (8), p.917-924 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c497t-1b1939dadb2900781c75faff72a43442dd58113045b13f265516f2719a10f5623 |
---|---|
cites | |
container_end_page | 924 |
container_issue | 8 |
container_start_page | 917 |
container_title | International immunology |
container_volume | 14 |
creator | Sugiura, Tomoko Harigai, Masayoshi Kawaguchi, Yasushi Takagi, Kae Fukasawa, Chikako Ohsako‐Higami, Satomi Ohta, Shuji Tanaka, Michi Hara, Masako Kamatani, Naoyuki |
description | In polymyositis (PM)/dermatomyositis (DM), various cytokines, especially macrophage‐derived cytokines such as IL‐1α, IL‐1β and tumor necrosis factor (TNF)‐α, are expressed in the inflammatory foci. We previously reported that IL‐15, a novel cytokine with a biological activity similar to that of IL‐2, is expressed in muscle cells in PM/DM. In the present study, we set out to investigate the regulation of IL‐15 in cultured myoblasts. Myoblasts constitutively produced a low level of IL‐15 and the production was augmented by stimulation with IFN‐γ, IL‐1α, IL‐1β, TNF‐α or lipopolysaccharide (LPS) in a dose‐dependent manner. These stimuli also enhanced the expression of IL‐15 mRNA. About 30–40% of IL‐15 was detected intracellularly, while the rest was released into the culture supernatant. Immunohistochemical staining revealed that intracellular IL‐15 was localized in the perinuclear area of the cytoplasm in the myoblasts. Despite the considerable amounts of intracellular IL‐15, the myoblasts predominantly expressed authentic IL‐15 mRNA isoform. This isoform generates IL‐15 with long signal peptide preprotein, which is all to be secreted. The biological activity of IL‐15 secreted from the myoblasts was examined using an IL‐15‐dependent murine T cell line, CTLL‐2. Culture supernatants of the myoblasts induced a proliferative response of CTLL‐2 and this was specifically inhibited by anti‐IL‐15 antibody. These results suggest that inflammatory stimuli induce the production of IL‐15 in the muscle cells in PM/DM, and IL‐15 may contribute to the immunopathogenesis by augmenting recruitment and activation of the infiltrating T cells. Blocking of IL‐15 production might be of therapeutic value in PM/DM. |
doi_str_mv | 10.1093/intimm/dxf062 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71951601</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>325363301</sourcerecordid><originalsourceid>FETCH-LOGICAL-c497t-1b1939dadb2900781c75faff72a43442dd58113045b13f265516f2719a10f5623</originalsourceid><addsrcrecordid>eNqFkcFqGzEQhkVJaNy0x16LyCG3TTTSaqU9JqZ1DIbkkIDxRcgrCZTurlxpF-JbHyHP2Cepgp0YcslpYOabn3_mR-g7kAsgNbv0_eC77tI8OVLRT2gCZUUKyoQ4QhNSc1ZIEPIEfUnpkRDCaM0-oxOgUIqKygm6m_dNtDpZg-eLf3-fgeNNDGZsBh96HBzuxtS0Fje2bRP2Pd6EdtttQ_KDT1j3BhsbOz2E195XdOx0m-y3fT1FD79-3k9visXtbD69WhRNWYuhgDXUrDbarGlNiJDQCO60c4LqkpUlNYZLAEZKvgbmaMU5VI4KqDUQxyvKTtH5Tjfb_TPaNKjOpxeXurdhTCqjeYXAhyBILvO_ZAbP3oGPYYx9PkJlLUKZLEWGih3UxJBStE5tou903Cog6iUQtQtE7QLJ_I-96LjurDnQ-wQOgj4N9ultruNvVQkmuLpZrtRSXK9Ws-lUzdh_maqXbQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195023847</pqid></control><display><type>article</type><title>Increased IL‐15 production of muscle cells in polymyositis and dermatomyositis</title><source>Oxford Journals Online</source><creator>Sugiura, Tomoko ; Harigai, Masayoshi ; Kawaguchi, Yasushi ; Takagi, Kae ; Fukasawa, Chikako ; Ohsako‐Higami, Satomi ; Ohta, Shuji ; Tanaka, Michi ; Hara, Masako ; Kamatani, Naoyuki</creator><creatorcontrib>Sugiura, Tomoko ; Harigai, Masayoshi ; Kawaguchi, Yasushi ; Takagi, Kae ; Fukasawa, Chikako ; Ohsako‐Higami, Satomi ; Ohta, Shuji ; Tanaka, Michi ; Hara, Masako ; Kamatani, Naoyuki</creatorcontrib><description>In polymyositis (PM)/dermatomyositis (DM), various cytokines, especially macrophage‐derived cytokines such as IL‐1α, IL‐1β and tumor necrosis factor (TNF)‐α, are expressed in the inflammatory foci. We previously reported that IL‐15, a novel cytokine with a biological activity similar to that of IL‐2, is expressed in muscle cells in PM/DM. In the present study, we set out to investigate the regulation of IL‐15 in cultured myoblasts. Myoblasts constitutively produced a low level of IL‐15 and the production was augmented by stimulation with IFN‐γ, IL‐1α, IL‐1β, TNF‐α or lipopolysaccharide (LPS) in a dose‐dependent manner. These stimuli also enhanced the expression of IL‐15 mRNA. About 30–40% of IL‐15 was detected intracellularly, while the rest was released into the culture supernatant. Immunohistochemical staining revealed that intracellular IL‐15 was localized in the perinuclear area of the cytoplasm in the myoblasts. Despite the considerable amounts of intracellular IL‐15, the myoblasts predominantly expressed authentic IL‐15 mRNA isoform. This isoform generates IL‐15 with long signal peptide preprotein, which is all to be secreted. The biological activity of IL‐15 secreted from the myoblasts was examined using an IL‐15‐dependent murine T cell line, CTLL‐2. Culture supernatants of the myoblasts induced a proliferative response of CTLL‐2 and this was specifically inhibited by anti‐IL‐15 antibody. These results suggest that inflammatory stimuli induce the production of IL‐15 in the muscle cells in PM/DM, and IL‐15 may contribute to the immunopathogenesis by augmenting recruitment and activation of the infiltrating T cells. Blocking of IL‐15 production might be of therapeutic value in PM/DM.</description><identifier>ISSN: 0953-8178</identifier><identifier>ISSN: 1460-2377</identifier><identifier>EISSN: 1460-2377</identifier><identifier>DOI: 10.1093/intimm/dxf062</identifier><identifier>PMID: 12147628</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Animals ; Case-Control Studies ; Cell Line ; Cells, Cultured ; Cytokines - pharmacology ; dermatomyositis ; Dermatomyositis - genetics ; Dermatomyositis - immunology ; Gene Expression ; Humans ; IL‐15 ; Immunohistochemistry ; Inflammation Mediators - metabolism ; Interleukin-15 - biosynthesis ; Interleukin-15 - genetics ; Lipopolysaccharides - pharmacology ; Lymphocyte Activation ; Mice ; muscle cells ; Myoblasts, Skeletal - drug effects ; Myoblasts, Skeletal - immunology ; polymyositis ; Polymyositis - genetics ; Polymyositis - immunology ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; T-Lymphocytes - immunology</subject><ispartof>International immunology, 2002-08, Vol.14 (8), p.917-924</ispartof><rights>Copyright Oxford University Press(England) Aug 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c497t-1b1939dadb2900781c75faff72a43442dd58113045b13f265516f2719a10f5623</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12147628$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sugiura, Tomoko</creatorcontrib><creatorcontrib>Harigai, Masayoshi</creatorcontrib><creatorcontrib>Kawaguchi, Yasushi</creatorcontrib><creatorcontrib>Takagi, Kae</creatorcontrib><creatorcontrib>Fukasawa, Chikako</creatorcontrib><creatorcontrib>Ohsako‐Higami, Satomi</creatorcontrib><creatorcontrib>Ohta, Shuji</creatorcontrib><creatorcontrib>Tanaka, Michi</creatorcontrib><creatorcontrib>Hara, Masako</creatorcontrib><creatorcontrib>Kamatani, Naoyuki</creatorcontrib><title>Increased IL‐15 production of muscle cells in polymyositis and dermatomyositis</title><title>International immunology</title><addtitle>Int. Immunol</addtitle><description>In polymyositis (PM)/dermatomyositis (DM), various cytokines, especially macrophage‐derived cytokines such as IL‐1α, IL‐1β and tumor necrosis factor (TNF)‐α, are expressed in the inflammatory foci. We previously reported that IL‐15, a novel cytokine with a biological activity similar to that of IL‐2, is expressed in muscle cells in PM/DM. In the present study, we set out to investigate the regulation of IL‐15 in cultured myoblasts. Myoblasts constitutively produced a low level of IL‐15 and the production was augmented by stimulation with IFN‐γ, IL‐1α, IL‐1β, TNF‐α or lipopolysaccharide (LPS) in a dose‐dependent manner. These stimuli also enhanced the expression of IL‐15 mRNA. About 30–40% of IL‐15 was detected intracellularly, while the rest was released into the culture supernatant. Immunohistochemical staining revealed that intracellular IL‐15 was localized in the perinuclear area of the cytoplasm in the myoblasts. Despite the considerable amounts of intracellular IL‐15, the myoblasts predominantly expressed authentic IL‐15 mRNA isoform. This isoform generates IL‐15 with long signal peptide preprotein, which is all to be secreted. The biological activity of IL‐15 secreted from the myoblasts was examined using an IL‐15‐dependent murine T cell line, CTLL‐2. Culture supernatants of the myoblasts induced a proliferative response of CTLL‐2 and this was specifically inhibited by anti‐IL‐15 antibody. These results suggest that inflammatory stimuli induce the production of IL‐15 in the muscle cells in PM/DM, and IL‐15 may contribute to the immunopathogenesis by augmenting recruitment and activation of the infiltrating T cells. Blocking of IL‐15 production might be of therapeutic value in PM/DM.</description><subject>Animals</subject><subject>Case-Control Studies</subject><subject>Cell Line</subject><subject>Cells, Cultured</subject><subject>Cytokines - pharmacology</subject><subject>dermatomyositis</subject><subject>Dermatomyositis - genetics</subject><subject>Dermatomyositis - immunology</subject><subject>Gene Expression</subject><subject>Humans</subject><subject>IL‐15</subject><subject>Immunohistochemistry</subject><subject>Inflammation Mediators - metabolism</subject><subject>Interleukin-15 - biosynthesis</subject><subject>Interleukin-15 - genetics</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Lymphocyte Activation</subject><subject>Mice</subject><subject>muscle cells</subject><subject>Myoblasts, Skeletal - drug effects</subject><subject>Myoblasts, Skeletal - immunology</subject><subject>polymyositis</subject><subject>Polymyositis - genetics</subject><subject>Polymyositis - immunology</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>T-Lymphocytes - immunology</subject><issn>0953-8178</issn><issn>1460-2377</issn><issn>1460-2377</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqFkcFqGzEQhkVJaNy0x16LyCG3TTTSaqU9JqZ1DIbkkIDxRcgrCZTurlxpF-JbHyHP2Cepgp0YcslpYOabn3_mR-g7kAsgNbv0_eC77tI8OVLRT2gCZUUKyoQ4QhNSc1ZIEPIEfUnpkRDCaM0-oxOgUIqKygm6m_dNtDpZg-eLf3-fgeNNDGZsBh96HBzuxtS0Fje2bRP2Pd6EdtttQ_KDT1j3BhsbOz2E195XdOx0m-y3fT1FD79-3k9visXtbD69WhRNWYuhgDXUrDbarGlNiJDQCO60c4LqkpUlNYZLAEZKvgbmaMU5VI4KqDUQxyvKTtH5Tjfb_TPaNKjOpxeXurdhTCqjeYXAhyBILvO_ZAbP3oGPYYx9PkJlLUKZLEWGih3UxJBStE5tou903Cog6iUQtQtE7QLJ_I-96LjurDnQ-wQOgj4N9ultruNvVQkmuLpZrtRSXK9Ws-lUzdh_maqXbQ</recordid><startdate>20020801</startdate><enddate>20020801</enddate><creator>Sugiura, Tomoko</creator><creator>Harigai, Masayoshi</creator><creator>Kawaguchi, Yasushi</creator><creator>Takagi, Kae</creator><creator>Fukasawa, Chikako</creator><creator>Ohsako‐Higami, Satomi</creator><creator>Ohta, Shuji</creator><creator>Tanaka, Michi</creator><creator>Hara, Masako</creator><creator>Kamatani, Naoyuki</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20020801</creationdate><title>Increased IL‐15 production of muscle cells in polymyositis and dermatomyositis</title><author>Sugiura, Tomoko ; Harigai, Masayoshi ; Kawaguchi, Yasushi ; Takagi, Kae ; Fukasawa, Chikako ; Ohsako‐Higami, Satomi ; Ohta, Shuji ; Tanaka, Michi ; Hara, Masako ; Kamatani, Naoyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c497t-1b1939dadb2900781c75faff72a43442dd58113045b13f265516f2719a10f5623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Case-Control Studies</topic><topic>Cell Line</topic><topic>Cells, Cultured</topic><topic>Cytokines - pharmacology</topic><topic>dermatomyositis</topic><topic>Dermatomyositis - genetics</topic><topic>Dermatomyositis - immunology</topic><topic>Gene Expression</topic><topic>Humans</topic><topic>IL‐15</topic><topic>Immunohistochemistry</topic><topic>Inflammation Mediators - metabolism</topic><topic>Interleukin-15 - biosynthesis</topic><topic>Interleukin-15 - genetics</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Lymphocyte Activation</topic><topic>Mice</topic><topic>muscle cells</topic><topic>Myoblasts, Skeletal - drug effects</topic><topic>Myoblasts, Skeletal - immunology</topic><topic>polymyositis</topic><topic>Polymyositis - genetics</topic><topic>Polymyositis - immunology</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>T-Lymphocytes - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sugiura, Tomoko</creatorcontrib><creatorcontrib>Harigai, Masayoshi</creatorcontrib><creatorcontrib>Kawaguchi, Yasushi</creatorcontrib><creatorcontrib>Takagi, Kae</creatorcontrib><creatorcontrib>Fukasawa, Chikako</creatorcontrib><creatorcontrib>Ohsako‐Higami, Satomi</creatorcontrib><creatorcontrib>Ohta, Shuji</creatorcontrib><creatorcontrib>Tanaka, Michi</creatorcontrib><creatorcontrib>Hara, Masako</creatorcontrib><creatorcontrib>Kamatani, Naoyuki</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sugiura, Tomoko</au><au>Harigai, Masayoshi</au><au>Kawaguchi, Yasushi</au><au>Takagi, Kae</au><au>Fukasawa, Chikako</au><au>Ohsako‐Higami, Satomi</au><au>Ohta, Shuji</au><au>Tanaka, Michi</au><au>Hara, Masako</au><au>Kamatani, Naoyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased IL‐15 production of muscle cells in polymyositis and dermatomyositis</atitle><jtitle>International immunology</jtitle><addtitle>Int. Immunol</addtitle><date>2002-08-01</date><risdate>2002</risdate><volume>14</volume><issue>8</issue><spage>917</spage><epage>924</epage><pages>917-924</pages><issn>0953-8178</issn><issn>1460-2377</issn><eissn>1460-2377</eissn><abstract>In polymyositis (PM)/dermatomyositis (DM), various cytokines, especially macrophage‐derived cytokines such as IL‐1α, IL‐1β and tumor necrosis factor (TNF)‐α, are expressed in the inflammatory foci. We previously reported that IL‐15, a novel cytokine with a biological activity similar to that of IL‐2, is expressed in muscle cells in PM/DM. In the present study, we set out to investigate the regulation of IL‐15 in cultured myoblasts. Myoblasts constitutively produced a low level of IL‐15 and the production was augmented by stimulation with IFN‐γ, IL‐1α, IL‐1β, TNF‐α or lipopolysaccharide (LPS) in a dose‐dependent manner. These stimuli also enhanced the expression of IL‐15 mRNA. About 30–40% of IL‐15 was detected intracellularly, while the rest was released into the culture supernatant. Immunohistochemical staining revealed that intracellular IL‐15 was localized in the perinuclear area of the cytoplasm in the myoblasts. Despite the considerable amounts of intracellular IL‐15, the myoblasts predominantly expressed authentic IL‐15 mRNA isoform. This isoform generates IL‐15 with long signal peptide preprotein, which is all to be secreted. The biological activity of IL‐15 secreted from the myoblasts was examined using an IL‐15‐dependent murine T cell line, CTLL‐2. Culture supernatants of the myoblasts induced a proliferative response of CTLL‐2 and this was specifically inhibited by anti‐IL‐15 antibody. These results suggest that inflammatory stimuli induce the production of IL‐15 in the muscle cells in PM/DM, and IL‐15 may contribute to the immunopathogenesis by augmenting recruitment and activation of the infiltrating T cells. Blocking of IL‐15 production might be of therapeutic value in PM/DM.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>12147628</pmid><doi>10.1093/intimm/dxf062</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0953-8178 |
ispartof | International immunology, 2002-08, Vol.14 (8), p.917-924 |
issn | 0953-8178 1460-2377 1460-2377 |
language | eng |
recordid | cdi_proquest_miscellaneous_71951601 |
source | Oxford Journals Online |
subjects | Animals Case-Control Studies Cell Line Cells, Cultured Cytokines - pharmacology dermatomyositis Dermatomyositis - genetics Dermatomyositis - immunology Gene Expression Humans IL‐15 Immunohistochemistry Inflammation Mediators - metabolism Interleukin-15 - biosynthesis Interleukin-15 - genetics Lipopolysaccharides - pharmacology Lymphocyte Activation Mice muscle cells Myoblasts, Skeletal - drug effects Myoblasts, Skeletal - immunology polymyositis Polymyositis - genetics Polymyositis - immunology RNA, Messenger - genetics RNA, Messenger - metabolism T-Lymphocytes - immunology |
title | Increased IL‐15 production of muscle cells in polymyositis and dermatomyositis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T02%3A38%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20IL%E2%80%9015%20production%20of%20muscle%20cells%20in%20polymyositis%20and%20dermatomyositis&rft.jtitle=International%20immunology&rft.au=Sugiura,%20Tomoko&rft.date=2002-08-01&rft.volume=14&rft.issue=8&rft.spage=917&rft.epage=924&rft.pages=917-924&rft.issn=0953-8178&rft.eissn=1460-2377&rft_id=info:doi/10.1093/intimm/dxf062&rft_dat=%3Cproquest_cross%3E325363301%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c497t-1b1939dadb2900781c75faff72a43442dd58113045b13f265516f2719a10f5623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=195023847&rft_id=info:pmid/12147628&rfr_iscdi=true |